Lpl Financial LLC Cara Therapeutics, Inc. Transaction History

Lpl Financial LLC

  • $218 Billion
  • Q3 2024

A detailed history of Lpl Financial LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 149,045 shares of CARA stock, worth $707,963. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149,045
Previous 151,195 1.42%
Holding current value
$707,963
Previous $39,000 17.95%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$0.26 - $0.38 $559 - $817
-2,150 Reduced 1.42%
149,045 $46,000
Q2 2024

Aug 07, 2024
BUY
$0.24 - $0.92 $103 - $396
431 Added 0.29%
151,195 $39,000
Q1 2024

May 10, 2024
SELL
$0.52 - $1.05 $2,475 - $4,999
-4,761 Reduced 3.06%
150,764 $137,000
Q4 2023

Feb 14, 2024
SELL
$0.6 - $1.65 $10,524 - $28,941
-17,540 Reduced 10.13%
155,525 $115,000
Q3 2023

Nov 13, 2023
SELL
$1.67 - $3.33 $131 - $263
-79 Reduced 0.05%
173,065 $290,000
Q2 2023

Jul 31, 2023
SELL
$2.83 - $4.94 $4,878 - $8,516
-1,724 Reduced 0.99%
173,144 $489,000
Q1 2023

May 10, 2023
SELL
$4.89 - $12.27 $4,811 - $12,073
-984 Reduced 0.56%
174,868 $858,000
Q4 2022

Feb 07, 2023
SELL
$8.88 - $12.77 $19,740 - $28,387
-2,223 Reduced 1.25%
175,852 $1.89 Million
Q3 2022

Nov 14, 2022
BUY
$8.24 - $12.56 $73,130 - $111,470
8,875 Added 5.25%
178,075 $1.67 Million
Q2 2022

Aug 12, 2022
BUY
$7.45 - $13.84 $76,369 - $141,873
10,251 Added 6.45%
169,200 $1.55 Million
Q1 2022

May 16, 2022
SELL
$9.94 - $12.65 $7,524 - $9,576
-757 Reduced 0.47%
158,949 $1.93 Million
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $90,908 - $137,537
-7,582 Reduced 4.53%
159,706 $1.95 Million
Q3 2021

Nov 15, 2021
BUY
$11.55 - $16.06 $117,128 - $162,864
10,141 Added 6.45%
167,288 $2.59 Million
Q2 2021

Aug 13, 2021
BUY
$12.38 - $29.19 $98,445 - $232,118
7,952 Added 5.33%
157,147 $2.24 Million
Q1 2021

May 14, 2021
SELL
$15.07 - $21.71 $12,779 - $18,410
-848 Reduced 0.57%
149,195 $3.24 Million
Q4 2020

Feb 12, 2021
BUY
$12.72 - $16.16 $6,372 - $8,096
501 Added 0.34%
150,043 $2.27 Million
Q3 2020

Nov 09, 2020
SELL
$12.34 - $17.92 $26,518 - $38,510
-2,149 Reduced 1.42%
149,542 $1.9 Million
Q2 2020

Aug 13, 2020
BUY
$12.39 - $17.33 $32,350 - $45,248
2,611 Added 1.75%
151,691 $2.59 Million
Q1 2020

May 14, 2020
BUY
$9.12 - $17.78 $6,274 - $12,232
688 Added 0.46%
149,080 $1.97 Million
Q4 2019

Feb 14, 2020
BUY
$16.11 - $25.98 $192,836 - $310,980
11,970 Added 8.77%
148,392 $2.39 Million
Q3 2019

Nov 13, 2019
SELL
$18.28 - $26.91 $10,054 - $14,800
-550 Reduced 0.4%
136,422 $2.49 Million
Q2 2019

Aug 09, 2019
BUY
$17.68 - $21.57 $140,732 - $171,697
7,960 Added 6.17%
136,972 $2.95 Million
Q1 2019

May 08, 2019
BUY
$14.41 - $19.64 $114,055 - $155,450
7,915 Added 6.54%
129,012 $2.53 Million
Q4 2018

Feb 07, 2019
SELL
$12.45 - $23.47 $5,727 - $10,796
-460 Reduced 0.38%
121,097 $1.57 Million
Q3 2018

Nov 14, 2018
SELL
$17.57 - $23.95 $15,285 - $20,836
-870 Reduced 0.71%
121,557 $2.91 Million
Q2 2018

Aug 14, 2018
BUY
$11.6 - $19.27 $114,329 - $189,925
9,856 Added 8.76%
122,427 $2.34 Million
Q1 2018

May 15, 2018
BUY
$11.77 - $16.08 $451,202 - $616,426
38,335 Added 51.64%
112,571 $1.39 Million
Q4 2017

Feb 14, 2018
BUY
$11.86 - $14.08 $214,559 - $254,721
18,091 Added 32.22%
74,236 $909,000
Q3 2017

Nov 14, 2017
SELL
$12.6 - $16.34 $32,886 - $42,647
-2,610 Reduced 4.44%
56,145 $769,000
Q2 2017

Aug 14, 2017
BUY
N/A
58,755
58,755 $904,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $255M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email